Description:Teduglutide is a dipeptidyl peptidase IV resistant glucagon-like peptide 2 (GLP-2) analogue. Teduglutide is associated with trophic effects on gut mucosa. Teduglutide can be used for the research of short bowel syndrome (SBS) and Crohn's disease (CD).
Molecular Formula:C164H252N44O55S
Molecular Weight:3752.08000
Exact Mass:3749.80000
PSA:1649.52000
LogP:1.01630
Teduglutide is a GLP-2 analog engineered for the treatment of short bowel syndrome. Its core synthesis involves solid-phase peptide chemistry targeting intestinal mucosal growth. The molecular formula is C179H285N47O50S and CAS No. 364732-77-2.
Contraindicated in active malignancies or history of colorectal cancer. Requires strict cold chain storage at 2°C to 8°C. Administration must be supervised by specialists due to potential risks of gastrointestinal adverse events.